FDA Import Refusal AEK-2305220-9/5/1 — Strides Pharma, Inc.
The FDA refused shipment AEK-2305220-9/5/1 from Strides Pharma, Inc. (United States) on August 16, 2016. The refused product falls under Drugs and Biologics — BUPROPION HCL (ANTI-DEPRESSANT). Cited charge: 179 This firm has 4 other import refusals on record.
Refusal Details
- Date
- August 16, 2016
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61NDY05 BUPROPION HCL (ANTI-DEPRESSANT)
- Charges
- 179